- Home
- BEEM vs OVID Comparison
BEEM vs OVID Comparison
Compare BEEM & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- OVID
- Stock Information
- Founded
- BEEM 2006
- OVID 2014
- Country
- BEEM United States
- OVID United States
- Employees
- BEEM N/A
- OVID N/A
- Industry
- BEEM Semiconductors
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- OVID Health Care
- Exchange
- BEEM Nasdaq
- OVID Nasdaq
- Market Cap
- BEEM 49.3M
- OVID 54.1M
- IPO Year
- BEEM N/A
- OVID 2017
- Fundamental
- Price
- BEEM $3.03
- OVID $0.74
- Analyst Decision
- BEEM Strong Buy
- OVID Strong Buy
- Analyst Count
- BEEM 4
- OVID 5
- Target Price
- BEEM $9.00
- OVID $4.04
- AVG Volume (30 Days)
- BEEM 362.7K
- OVID 384.9K
- Earning Date
- BEEM 11-14-2024
- OVID 03-07-2025
- Dividend Yield
- BEEM N/A
- OVID N/A
- EPS Growth
- BEEM N/A
- OVID N/A
- EPS
- BEEM N/A
- OVID N/A
- Revenue
- BEEM $60,883,000.00
- OVID $631,695.00
- Revenue This Year
- BEEM N/A
- OVID $71.38
- Revenue Next Year
- BEEM $24.12
- OVID $5,144.81
- P/E Ratio
- BEEM N/A
- OVID N/A
- Revenue Growth
- BEEM 10.25
- OVID 113.21
- 52 Week Low
- BEEM $2.62
- OVID $0.68
- 52 Week High
- BEEM $8.48
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- BEEM 43.75
- OVID 25.31
- Support Level
- BEEM $2.92
- OVID $0.75
- Resistance Level
- BEEM $3.31
- OVID $1.01
- Average True Range (ATR)
- BEEM 0.34
- OVID 0.07
- MACD
- BEEM 0.00
- OVID -0.02
- Stochastic Oscillator
- BEEM 10.28
- OVID 6.25
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.